query
ai
Login
Registrieren
Infos
Werben auf fleebs.com
Seite indizieren lassen
Einstellungen
Datenschutz
Nutzungsbedingungen
Impressum
Details werden geladen...
https://www.biospace.com/deals/nuvectis-haisco-ink-up-to-1-4b-deal-for-two-late-stage-programs
Teilen bei
Facebook
Teilen bei
Twitter
Teilen bei
Pinterest
Per Mail empfehlen
Nuvectis, Haisco ink up to $1.4B deal for two late-stage programs - BioSpace
China’s Haisco Pharmaceutical continues to wield deals, this time out-licensing rights to two late-stage programs to New Jersey biotech Nuvectis.
Ähnliche Seiten
Regeneron, Parabilis set out to create new drug class in deal worth up to $2.3B - BioSpace
https://www.biospace.com/deals/regeneron-parabilis-set-out-to-create-new-drug-class-in-deal-worth-up-to-2-3b
Tour de Hongrie: Tim Merlier powers to third stage win on final day while Jakob Söderqvist overcomes late crash for GC title | Cyclingnews
https://www.cyclingnews.com/pro-cycling/racing/tour-de-hongrie-tim-merlier-powers-to-third-stage-win-on-final-day-while-jakob-soderqvist-overcomes-late-crash-for-gc-title/
EU strikes migration deal for more deportations and detention centers abroad – Winnipeg Free Press
https://www.winnipegfreepress.com/world/2026/06/02/eu-strikes-migration-deal-for-more-deportations-and-detention-centers-abroad
England fans can snap up classic £50 retro shirt for £9.79 ahead of the World Cup with deal - Birmingham Live
https://www.birminghammail.co.uk/sport/football/football-news/england-retro-shirt-world-cup-34020550
'Close the book and go for the next one' - From stage wins and the pink jersey to breakaways and crashes, inside XDS Astana's up and down Giro d'Italia | Cyclingnews
https://www.cyclingnews.com/pro-cycling/teams-riders/close-the-book-and-go-for-the-next-one-from-stage-wins-and-the-pink-jersey-to-breakaways-and-crashes-inside-xds-astanas-up-and-down-giro-d-italia/
Haisco Enters into Exclusive License Agreement with Nuvectis for Two Drug Candidates in Oncology and Complement Indications | The Manila Times
https://www.manilatimes.net/2026/06/23/tmt-newswire/pr-newswire/haisco-enters-into-exclusive-license-agreement-with-nuvectis-for-two-drug-candidates-in-oncology-and-complement-indications/2371120
Please enable JavaScript to continue using this application.